ISOPTO-CARPINE

This brand name is authorized in Australia, Canada, Estonia, Finland, Hong Kong, New Zealand, Singapore, United States

Active ingredients

The drug ISOPTO-CARPINE contains one active pharmaceutical ingredient (API):

1 Pilocarpine UNII 0WW6D218XJ - PILOCARPINE HYDROCHLORIDE

Pilocarpine is a cholinergic parasympathomimetic agent exerting a broad spectrum of pharmacologic effects with predominant muscarinic action. Pilocarpine, in appropriate dosage, can increase secretion by exocrine glands such as the sweat, salivary, lacrimal, gastric, pancreatic and intestinal glands and the mucous cells of the respiratory tract. Read about Pilocarpine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EB01	Pilocarpine	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EB Parasympathomimetics
Discover more medicines within S01EB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2595N, 2596P, 2598R, 5536J, 5537K, 5538L
Country: CA	Health Products and Food Branch	Identifier(s): 00000868, 00000884
Country: EE	Ravimiamet	Identifier(s): 1123759, 1706385
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 536037, 536052
Country: HK	Department of Health Drug Office	Identifier(s): 16907, 16908, 17266
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 935, 936, 938
Country: SG	Health Sciences Authority	Identifier(s): 04712P, 04713P
Country: US	FDA, National Drug Code	Identifier(s): 0998-0203, 0998-0204, 0998-0206